These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18472735)

  • 1. [Terbinafine induced hepatitis with persistent cholestasis].
    Gendre G; Buclin T; Morard I; Fontannaz J; Berney JL
    Rev Med Suisse; 2008 Mar; 4(149):736-9. PubMed ID: 18472735
    [No Abstract]   [Full Text] [Related]  

  • 2. [Terbinafine and cholestatic hepatitis].
    Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC
    Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769
    [No Abstract]   [Full Text] [Related]  

  • 3. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute hepatitis associated with terbinafine].
    Vivas S; Rodríguez M; Palacio MA; Cadenas F; Lomo J; Rodrigo L
    Gastroenterol Hepatol; 1997 Nov; 20(9):456-8. PubMed ID: 9445740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine-associated hepatotoxicity.
    Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
    Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis associated with terbinafine treatment.
    Lowe G; Green C; Jennings P
    BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443524
    [No Abstract]   [Full Text] [Related]  

  • 7. [Colestasic toxic hepatitis caused by terbinafine: case report].
    Burstein Z; Vildósola H; Lozano Z; Verona R; Vargas G
    Rev Gastroenterol Peru; 2004; 24(4):357-62. PubMed ID: 15614306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute hepatitis related to the ingestion of terbinafine].
    Vantaux P; Grasset D; Nougue J; Lagier E; Seigneuric C
    Gastroenterol Clin Biol; 1996; 20(4):402-3. PubMed ID: 8758509
    [No Abstract]   [Full Text] [Related]  

  • 9. Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.
    Mallat A; Zafrani ES; Metreau JM; Dhumeaux D
    Dig Dis Sci; 1997 Jul; 42(7):1486-8. PubMed ID: 9246051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis attributed to the use of terbinafine].
    Boldewijn OY; Ottervanger JP; Mostart CM; Janssens AR; Calame J; Jonkers GJ
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):669-72. PubMed ID: 8668241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terbinafine-induced hepatitis and pancytopenia.
    Conjeevaram G; Vongthavaravat V; Sumner R; Koff RS
    Dig Dis Sci; 2001 Aug; 46(8):1714-6. PubMed ID: 11508672
    [No Abstract]   [Full Text] [Related]  

  • 12. A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum.
    Kumar K; Gill A; Shafei R; Wright JL
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25480138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestatic jaundice due to terbinafine.
    Dwyer CM; White MI; Sinclair TS
    Br J Dermatol; 1997 Jun; 136(6):976-7. PubMed ID: 9217846
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe liver damage on terbinafine.
    Prescrire Int; 2002 Feb; 11(57):16. PubMed ID: 11985370
    [No Abstract]   [Full Text] [Related]  

  • 15. Terbinafine hepatotoxicity: case report and review of the literature.
    Fernandes NF; Geller SA; Fong TL
    Am J Gastroenterol; 1998 Mar; 93(3):459-60. PubMed ID: 9517658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terbinafine-associated hepatic injury.
    van 't Wout JW; Herrmann WA; de Vries RA; Stricker BH
    J Hepatol; 1994 Jul; 21(1):115-7. PubMed ID: 7963410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.
    Gupta AK; del Rosso JQ; Lynde CW; Brown GH; Shear NH
    Clin Exp Dermatol; 1998 Mar; 23(2):64-7. PubMed ID: 9692307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Terbinafine-induced cholestatic liver injury].
    Shiloah E; Horowiz M; Zecler E
    Harefuah; 1997 Jul; 133(1-2):11-2, 80-1. PubMed ID: 9332048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terbinafine-induced cholestatic liver disease.
    Lazaros GA; Papatheodoridis GV; Delladetsima JK; Tassopoulos NC
    J Hepatol; 1996 Jun; 24(6):753-6. PubMed ID: 8835752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.
    Fontana RJ; Cirulli ET; Gu J; Kleiner D; Ostrov D; Phillips E; Schutte R; Barnhart H; Chalasani N; Watkins PB; Hoofnagle JH
    J Hepatol; 2018 Dec; 69(6):1317-1325. PubMed ID: 30138689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.